サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722456

腎バイオマーカー市場レポート：バイオマーカータイプ別、診断手法別、エンドユーザー別、地域別、2025年～2033年

Renal Biomarkers Market Report by Biomarker Type, Diagnostic Technique, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 148 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
腎バイオマーカー市場レポート：バイオマーカータイプ別、診断手法別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の腎バイオマーカー市場規模は2024年に14億米ドルに達しました。今後、IMARC Groupは、2033年までに市場は26億米ドルに達し、2025年から2033年にかけて6.54%の成長率（CAGR）を示すと予測しています。高血圧、糖尿病、心臓病など、公衆衛生への関心の高まりとその主な危険因子が市場を強化しています。

腎バイオマーカーとは、尿検査で検出される細胞、タンパク質、脂質、マイクロRNA、遺伝子、代謝物、プロテオミクスパターンのことです。腎臓の糸球体濾過量（GFR）を測定し、腎臓の適切な機能を分析したり、病原プロセスや治療介入に対する薬理学的反応を評価したりするのに役立ちます。腎バイオマーカーは、病気の進行予測や薬剤投与量の計算にも役立つため、世界中の病院や診断ラボで幅広く使用されています。

腎バイオマーカーの市場動向：

慢性腎臓病（CKD）は、かなりの罹患率と死亡率を伴う非伝染性疾患であり、徐々に世界の公衆衛生上の懸念となっています。CKD患者の増加は、市場の成長を促進する主要因の1つです。さらに、血中尿素窒素（BUN）、血清クレアチニン（SCr）、尿中アルブミン／タンパク質、排泄量などの腎バイオマーカーは、慢性腎臓病（CKD）の診断や疾患のモニタリングに使用されています。これに加えて、ヒトの腎疾患における新規の単一バイオマーカーやプロセス特異的バイオマーカーパネルに対する産業投資家の関心が世界中で高まっています。これらの新規バイオマーカーは重要な診断・予後情報を提供し、糸球体病、急性腎障害（AKI）、常染色体優性多発性嚢胞腎（ADPKD）の治療効果予測に役立ちます。これとは別に、腎バイオマーカーはあらゆる規模の検査室で利用しやすく、実現可能になってきています。これは、ゲノミクス、エピジェネティクス、トランスクリプトミクス、プロテオミクス、メタボロミクスの開発と統合とともに、市場にプラスの影響を与えています。ヘルスケア産業の急成長、高齢者人口の増加、世界のCKDの臨床試験数の増加などの他の要因も、市場の成長を促進すると予測されています。

本レポートで扱う主な質問

  • 2024年の世界の腎バイオマーカー市場規模は？
  • 2025年～2033年の腎バイオマーカー世界市場の予想成長率は？
  • 腎バイオマーカーの世界市場に対するCOVID-19の影響は？
  • 腎バイオマーカーの世界市場を牽引する主要因は？
  • バイオマーカータイプに基づく腎バイオマーカーの世界市場の内訳は？
  • 診断手法に基づく腎バイオマーカー世界市場の内訳は？
  • 腎バイオマーカーの世界市場のエンドユーザー別の区分は？
  • 腎バイオマーカーの世界市場における主要地域は？
  • 腎バイオマーカーの世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の腎バイオマーカー市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：バイオマーカータイプ別

  • 機能バイオマーカー
    • 主要セグメント
      • 血清クレアチニン
      • 血清シスタチンC
      • 尿アルブミン
  • タンパク質の上昇
    • 主要セグメント
      • 好中球ゼラチナーゼ関連リポカリン（NGAL）
      • 腎臓損傷分子-1
      • インターロイキン-18
  • その他

第7章 市場内訳：診断手法別

  • 酵素免疫測定（ELISA）
  • 粒子増強比濁免疫測定法（PETIA）
  • 比色分析
  • 化学発光免疫測定（CLIA）
  • 液体クロマトグラフィー質量分析法（LC-MS）

第8章 市場内訳：エンドユーザー別

  • 病院
  • 診断検査室
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Beckman Coulter Inc.（Danaher Corporation）
    • bioMerieux SA
    • BioPorto A/S
    • Bio-Rad Laboratories Inc.
    • Enzo Biochem Inc.
    • F. Hoffmann-La Roche AG
    • PerkinElmer Inc.
    • Randox Laboratories Ltd.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Renal Biomarkers Market: Major Drivers and Challenges
  • Figure 2: Global: Renal Biomarkers Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Renal Biomarkers Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Renal Biomarkers Market: Breakup by Biomarker Type (in %), 2024
  • Figure 5: Global: Renal Biomarkers Market: Breakup by Diagnostic Technique (in %), 2024
  • Figure 6: Global: Renal Biomarkers Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Renal Biomarkers Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Renal Biomarkers (Functional Biomarker) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Renal Biomarkers (Functional Biomarker) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Renal Biomarkers (Up-regulated Protein) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Renal Biomarkers (Up-regulated Protein) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Renal Biomarkers (Other Biomarker Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Renal Biomarkers (Other Biomarker Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Renal Biomarkers (Colorimetric Assay) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Renal Biomarkers (Colorimetric Assay) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Renal Biomarkers (Hospital) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Renal Biomarkers (Hospital) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Renal Biomarkers (Diagnostic Laboratory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Renal Biomarkers (Diagnostic Laboratory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Renal Biomarkers (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Renal Biomarkers (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Renal Biomarkers Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Renal Biomarkers Industry: SWOT Analysis
  • Figure 80: Global: Renal Biomarkers Industry: Value Chain Analysis
  • Figure 81: Global: Renal Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Renal Biomarkers Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Renal Biomarkers Market Forecast: Breakup by Biomarker Type (in Million USD), 2025-2033
  • Table 3: Global: Renal Biomarkers Market Forecast: Breakup by Diagnostic Technique (in Million USD), 2025-2033
  • Table 4: Global: Renal Biomarkers Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Renal Biomarkers Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Renal Biomarkers Market: Competitive Structure
  • Table 7: Global: Renal Biomarkers Market: Key Players
目次
Product Code: SR112025A5273

The global renal biomarkers market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.54% during 2025-2033. The increasing public health concerns and its main risk factors, including hypertension, diabetes, and heart diseases, are bolstering the market.

Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a urinalysis. They assist in determining the glomerular filtration rate (GFR) of kidneys to analyze their proper functioning and evaluating pathogenic processes or pharmacological responses to therapeutic interventions. As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.

Renal Biomarkers Market Trends:

Chronic kidney disease (CKD), non-communicable disease with considerable morbidity and mortality, has gradually become a public health concern globally and its main risk factors are diabetes, hypertension and heart diseases. The increasing number of individuals with CKD represents one of the key factors propelling the growth of the market. Moreover, renal biomarkers, including blood urea nitrogen (BUN), serum creatinine (SCr), urinary albumin/protein and volume excretion, are used in the diagnosis of chronic kidney disease (CKD) and monitoring of the disease. Besides this, there is a growing interest of industry investors in novel single biomarkers and process-specific biomarker panels in human renal diseases around the world. These novel biomarkers provide vital diagnostic and prognostic information and help predict response to the treatment of glomerulopathies, acute kidney injury (AKI), and autosomal dominant polycystic kidney disease (ADPKD). Apart from this, renal biomarkers are becoming accessible and feasible in all-sized laboratories. This, along with the development and integration of genomics, epigenetics, transcriptomics, proteomics, and metabolomics, is positively influencing the market. Some of the other factors, such as the burgeoning healthcare industry, the rising geriatric population, and the increasing number of clinical trials for CKD worldwide, are anticipated to facilitate the growth of the market.

Key Market Segmentation:

Breakup by Biomarker Type:

  • Functional Biomarker
  • Serum Creatinine
  • Serum Cystatin C
  • Urine Albumin
  • Up-regulated Protein
  • Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  • Kidney Injury Molecule-1
  • INTERLEUKIN-18
  • Others

Breakup by Diagnostic Technique:

  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Particle-enhanced Turbidimetric Immunoassay (PETIA)
  • Colorimetric Assay
  • Chemiluminescent Enzyme Immunoassay (CLIA)
  • Liquid Chromatography Mass Spectrometry (LC-MS)

Breakup by End User:

  • Hospital
  • Diagnostic Laboratory
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global renal biomarkers market in 2024?
  • 2.What is the expected growth rate of the global renal biomarkers market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global renal biomarkers market?
  • 4.What are the key factors driving the global renal biomarkers market?
  • 5.What is the breakup of the global renal biomarkers market based on the biomarker type?
  • 6.What is the breakup of the global renal biomarkers market based on the diagnostic technique?
  • 7.What is the breakup of the global renal biomarkers market based on end user?
  • 8.What are the key regions in the global renal biomarkers market?
  • 9.Who are the key players/companies in the global renal biomarkers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Renal Biomarkers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Biomarker Type

  • 6.1 Functional Biomarker
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Serum Creatinine
      • 6.1.2.2 Serum Cystatin C
      • 6.1.2.3 Urine Albumin
    • 6.1.3 Market Forecast
  • 6.2 Up-regulated Protein
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Neutrophil Gelatinase-Associated Lipocalin (NGAL)
      • 6.2.2.2 Kidney Injury Molecule-1
      • 6.2.2.3 INTERLEUKIN-18
    • 6.2.3 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Diagnostic Technique

  • 7.1 Enzyme-linked Immunosorbent Assay (ELISA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Particle-enhanced Turbidimetric Immunoassay (PETIA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Colorimetric Assay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Chemiluminescent Immunoassay (CLIA)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Liquid Chromatography Mass Spectrometry (LC-MS)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratory
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 BioPorto A/S
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bio-Rad Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Biochem Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 PerkinElmer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Randox Laboratories Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Siemens AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis